Mevalonic Acid Conversion via Fermentation and Catalytic Upgrading

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The existing methods for producing isoprene and other intermediates from petroleum are expensive and time-consuming, and there is a need for a sustainable, renewable source due to the depletion of fossil fuels.

Innovation Solution

Biobased production of mevalonic acid derivatives, such as mevalonolactone, through fermentation, followed by chemical conversions to produce isoprene and other intermediates like methyl vinyl ketone, using microbial pathways and catalysts to facilitate high-yielding and cost-effective synthesis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Ease of manufacture

If isoprene is obtained by fractionating petroleum, then isoprene can be produced, but the purification process is expensive and time-consuming

Engineering Contradiction:
Improveproduction cost and timeVSAvoidpurification efficiency
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The patent changes the source material parameter from petroleum to mevalonolactone (a renewable organic acid), and changes the production method parameter from fractionation to biochemical conversion followed by simple purification, thereby reducing both cost and time while maintaining productivity

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent extracts the isoprene production pathway from the petroleum fractionation process and replaces it with a dedicated biochemical route starting from mevalonolactone, eliminating the need for complex petroleum purification while achieving high-yield isoprene production

Inventive Principle:
Principle #2Taking out (Extraction)

2Ease of manufacture

If isoprene is obtained from naturally-occurring organisms, then isoprene can be produced sustainably, but the yield is commercially unattractive

Engineering Contradiction:
ImprovesustainabilityVSAvoidyield
Core Design Contradiction:
Ease of manufactureVSProductivity

Solution Approach 1:

The patent performs preliminary action by first converting mevalonolactone to mevalone, then to geranyl pyrophosphate, and finally to isoprene through a controlled multi-step biochemical pathway, ensuring high yield at each stage rather than relying on low-yield direct extraction from natural organisms

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent changes the production system parameter from natural organism extraction to controlled biochemical conversion using isolated enzymes and catalysts, thereby achieving both sustainability and commercially attractive yield levels

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Provides a cost-competitive and sustainable route for producing isoprene and other intermediates, reducing reliance on petroleum-based sources and enabling the production of diverse polymers and chemicals.

Implementation Method 1

Mevalonic acid, mevalonate, and mevalonolactone can be produced via fermentation

Methodology Applied
Scientific EffectFermentation: Fermentation

Implementation Method 2

The mevalonic acid or mevalonolactone can then be converted via chemical routes, such as dehydration and decarboxylation, to produce a variety of intermediates, such as isoprene and methyl vinyl ketone

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentEP4296365B1Processes for conversion of biologically derived mevalonic acid
Publication Date: 2026.04.15 VISOLIS
  • EP4296365B1 patent drawingFigure 1
  • EP4296365B1 patent drawing
  • EP4296365B1 patent drawing

AI summary

The invention relates to a process comprising reacting mevalonic acid, or a solution comprising mevalonic acid, to yield a first product or first product mixture, optionally in the presence of a solid catalyst and/or at elevated temperature and/or pressure. The invention further relates to a process comprising: (a) providing a microbial organism that expresses a biosynthetic mevalonic acid pathway; (b) growing the microbial organism in fermentation medium comprising suitable carbon substrates, whereby biobased mevalonic acid is produced; and (c) reacting said biobased mevalonic acid to yield a first product or first product mixture.